Open-market purchases and sales reported on SEC Forms 4 and 5, with each filing and its footnotes.
Since Nov 18, 2025
Transactions
51
Purchases
0
Sales
51
Purchase value
$0.00
Sale value
$37.48M
Values are shares multiplied by reported price when both were supplied, each trade counted once however many filers reported it.
Christophe JeanDirector
4Rule 10b5-1 plan disclosed
Filed Nov 18, 2026Period of report Nov 17, 20260001649904-26-000030
Transaction
Security
Shares
Price
ValueValue (shares × price)
Held after
Ownership
SaleNov 17, 2026
Common StockF1
5,000
$106.81
$534.05K
16,712
Direct
SaleNov 17, 2026
Common StockF1
2,500
$110.00
$275.00K
14,212
Direct
SaleNov 17, 2026
Common StockF1
2,500
$115.00
$287.50K
11,712
Direct
Filing footnotes · 2
F1The exercise and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 18, 2026.
F2The options fully vested upon the earlier of (i) 1 year from the date of grant or (ii) the date of the Issuer's next annual meeting of the stockholders.
Filed Sep 14, 2026Period of report Sep 14, 20260001649904-26-000026
Transaction
Security
Shares
Price
ValueValue (shares × price)
Held after
Ownership
SaleSep 14, 2026
Common StockF1F3
6,439
$101.7464
$655.15K
282,819
Direct
SaleSep 14, 2026
Common StockF1F4
30,746
$102.347
$3.15M
252,073
Direct
SaleSep 14, 2026
Common StockF1F5
8,698
$103.43
$899.63K
243,375
Direct
SaleSep 14, 2026
Common StockF1F6
1,817
$104.5487
$189.96K
241,558
Direct
SaleSep 14, 2026
Common StockF1F7
2,300
$105.19
$241.94K
239,258
Direct
Filing footnotes · 8
F1The exercise and sales reported in this form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 15, 2026.
F2Includes 242 shares acquired under the Rhythm Pharmaceuticals, Inc. employee stock purchase plan on 2-28-2026.
F3The price reported in Column 4 is a weighted average price. The securities were sold in multiple transactions at prices ranging from $100.96 to $101.95 per common stock. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F4The price reported in Column 4 is a weighted average price. The securities were sold in multiple transactions at prices ranging from $101.96 to $102.94 per common stock. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F5The price reported in Column 4 is a weighted average price. The securities were sold in multiple transactions at prices ranging from $102.97 to $103.96 per common stock. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F6The price reported in Column 4 is a weighted average price. The securities were sold in multiple transactions at prices ranging from $103.97 to $104.94 per common stock. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F7The price reported in Column 4 is a weighted average price. The securities were sold in multiple transactions at prices ranging from $105.00 to $105.31 per common stock. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F8The stock options were granted on February 8, 2017 and vested and became exercisable in three equal annual installments measured from January 6, 2017.
Filed Sep 1, 2026Period of report Aug 31, 20260001649904-26-000023
Transaction
Security
Shares
Price
ValueValue (shares × price)
Held after
Ownership
SaleAug 31, 2026
Common StockF1F2
23,072
$104.5871
$2.41M
153,726
Direct
SaleAug 31, 2026
Common StockF1F3
11,514
$105.3702
$1.21M
142,212
Direct
SaleAug 31, 2026
Common StockF1F4
28,188
$106.2029
$2.99M
114,024
Direct
Filing footnotes · 5
F1The exercise and sales reported in this form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 13, 2026.
F2The price reported in Column 4 is a weighted average price. The securities were sold in multiple transactions at prices ranging from $104.04 to $105.03 per common stock. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F3The price reported in Column 4 is a weighted average price. The securities were sold in multiple transactions at prices ranging from $105.04 to $106.01 per common stock. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F4The price reported in Column 4 is a weighted average price. The securities were sold in multiple transactions at prices ranging from $106.05 to $106.88 per common stock. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F5This option was granted on February 14, 2018 and the shares underlying this option vested in sixteen equal quarterly installments.
Filed Aug 17, 2026Period of report Aug 13, 20260001649904-26-000015
Transaction
Security
Shares
Price
ValueValue (shares × price)
Held after
Ownership
SaleAug 13, 2026
Common StockF1
5,079
$119.75
$608.21K
15,915
Direct
Filing footnotes · 2
F1The Exercise and sale reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 15, 2025.
F2The stock options were granted on February 9, 2022. The options vested and become exercisable in 16 substantially equal installments upon the Reporting Person's completion of each three full months of successive service to the Issuer following the grant date.
Filed Aug 17, 2026Period of report Aug 13, 20260001649904-26-000013
Transaction
Security
Shares
Price
ValueValue (shares × price)
Held after
Ownership
SaleAug 13, 2026
Common StockF1F2
2,007
$116.1093
$233.03K
8,051
Direct
SaleAug 13, 2026
Common StockF1F3
1,556
$117.0759
$182.17K
6,495
Direct
SaleAug 13, 2026
Common StockF1F4
3,400
$118.2843
$402.17K
3,095
Direct
SaleAug 13, 2026
Common StockF1F5
800
$119.1688
$95.34K
2,295
Direct
Filing footnotes · 5
F1The sales reported in the Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 14, 2026.
F2The price reported in Column 4 is a weighted average price. The securities were sold in multiple transactions at prices ranging from $115.67 to $116.62 per common stock. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F3The price reported in Column 4 is a weighted average price. The securities were sold in multiple transactions at prices ranging from $116.72 to $117.66 per common stock. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F4The price reported in Column 4 is a weighted average price. The securities were sold in multiple transactions at prices ranging from $117.73 to $118.71 per common stock. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F5The price reported in Column 4 is a weighted average price. The securities were sold in multiple transactions at prices ranging from $118.73 to $119.52 per common stock. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
Filed Aug 14, 2026Period of report Aug 13, 20260001649904-26-000009
Transaction
Security
Shares
Price
ValueValue (shares × price)
Held after
Ownership
SaleAug 13, 2026
Common StockF1
75,834
$117.3818
$8.90M
0
Direct
Filing footnotes · 3
F1The exercises and sales reported in the Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 14, 2026.
F2The stock options were granted on November 9, 2020. 25% of the shares subject to the option vested and become exercisable on November 9, 2021 and the remaining 75% of the shares subject to the option vested and become exercisable in 12 substantially equal installments upon the Reporting Person's completion of each three full months of successive service to the Issuer thereafter.
F3The stock options were granted on February 9, 2022. The options vested and became exercisable in 16 substantially equal installments upon the Reporting Person's completion of each three full months of successive service to the Issuer following the grant date.
Filed Aug 14, 2026Period of report Aug 12, 20260001649904-26-000007
Transaction
Security
Shares
Price
ValueValue (shares × price)
Held after
Ownership
SaleAug 12, 2026
Common StockF1F2
2,300
$111.7992
$257.14K
110,355
Direct
SaleAug 12, 2026
Common StockF1F3
1,000
$112.856
$112.86K
109,355
Direct
SaleAug 12, 2026
Common StockF1F4
3,605
$114.6955
$413.48K
105,750
Direct
SaleAug 12, 2026
Common StockF1F5
14,568
$115.427
$1.68M
91,182
Direct
SaleAug 12, 2026
Common StockF1F6
18,208
$116.4941
$2.12M
72,974
Direct
SaleAug 12, 2026
Common StockF1F7
17,319
$117.4686
$2.03M
55,655
Direct
Filing footnotes · 8
F1The exercise and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 13, 2026.
F2The price reported in Column 4 is a weighted average price. The securities were sold in multiple transactions at prices ranging from $111.58 to $112.30 per common stock. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F3The price reported in Column 4 is a weighted average price. The securities were sold in multiple transactions at prices ranging from $112.84 to $112.92 per common stock. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F4The price reported in Column 4 is a weighted average price. The securities were sold in multiple transactions at prices ranging from $114.01 to $115.00 per common stock. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F5The price reported in Column 4 is a weighted average price. The securities were sold in multiple transactions at prices ranging from $115.01 to $116.00 per common stock. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F6The price reported in Column 4 is a weighted average price. The securities were sold in multiple transactions at prices ranging from $116.01 to $117.00 per common stock. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F7The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $117.01 to $117.60 per share. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F8The stock options were granted on February 9, 2022. The options vest and become exercisable in 16 substantially equal installments upon the Reporting Person's completion of each three full months of successive service to the Issuer following the grant date.
Filed Jun 24, 2026Period of report Jun 22, 20260001104659-26-077305
Transaction
Security
Shares
Price
ValueValue (shares × price)
Held after
Ownership
SaleJun 22, 2026
Common StockF1F2
37,000
$100.3215
$3.71M
7,000
Direct
Filing footnotes · 3
F1The sales reported in the Form 4 were effected pursuant to a Rule 10b5-1 instruction adopted on December 15, 2025.
F2The price reported is a weighted average price. The securities were sold in multiple transactions at per share prices ranging from $100.00 to $100.91. The Reporting Person undertakes to provide upon request the SEC staff, the Issuer, or any shareholder of the Issuer, full information regarding the number of securities sold at each separate price within the range set forth in this footnote.
Filed May 19, 2026Period of report May 15, 20260001104659-26-063830
Transaction
Security
Shares
Price
ValueValue (shares × price)
Held after
Ownership
SaleMay 15, 2026
Common Stock
4,643
$92.21
$428.13K
0
Direct
Filing footnotes · 4
F1Includes an aggregate of 201 shares of Common Stock purchased pursuant to the Rhythm Pharmaceuticals, Inc. Employee Stock Purchase Plan.
F2The stock options were granted on February 14, 2025. The options vest and become exercisable in 16 substantially equal installments upon the Reporting Person's completion of each three full months of successive service to the Issuer following the grant date.
F3The stock options were granted on February 16, 2024. The options vest and become exercisable in 16 substantially equal installments upon the Reporting Person's completion of each three full months of successive service to the Issuer following the grant date.
F4The stock options were granted on April 4, 2023. The options vest and become exercisable as to 25% of the total shares on March 20, 2024 and, thereafter, as to the remaining 75% of the total shares in twelve equal quarterly installments of 6.25% beginning June 20, 2024 and ending March 20, 2027, subject to the Reporting Person's continued service on each such vesting date.
Filed Mar 6, 2026Period of report Mar 4, 20260001104659-26-024750
Transaction
Security
Shares
Price
ValueValue (shares × price)
Held after
Ownership
SaleMar 4, 2026
Common StockF1
5,614
$89.56
$502.79K
160
Direct
Filing footnotes · 2
F1Includes 21 shares of Common Stock purchased pursuant to the Rhythm Pharmaceuticals, Inc. Employee Stock Purchase Plan.
F2The stock options were granted on April 4, 2023. The options vest and become exercisable as to 25% of the total shares on March 20, 2024 and, thereafter, as to the remaining 75% of the total shares in twelve equal quarterly installments of 6.25% beginning June 20, 2024 and ending March 20, 2027, subject to the Reporting Person's continued service on each such vesting date.
Filed Feb 19, 2026Period of report Feb 17, 20260001104659-26-017729
Transaction
Security
Shares
Price
ValueValue (shares × price)
Held after
Ownership
SaleFeb 19, 2026
Common StockF1F6
1,308
$100.2698
$131.15K
113,589
Direct
SaleFeb 19, 2026
Common StockF1F7
1,692
$100.9189
$170.75K
111,897
Direct
SaleFeb 19, 2026
Common StockF1F8
800
$102.0951
$81.68K
111,097
Direct
SaleFeb 19, 2026
Common StockF1F9
585
$103.2828
$60.42K
110,512
Direct
SaleFeb 17, 2026
Common StockF1F2
1,200
$99.415
$119.30K
117,266
Direct
SaleFeb 17, 2026
Common StockF1F3
200
$100.52
$20.10K
117,066
Direct
SaleFeb 17, 2026
Common StockF1F4
900
$101.70
$91.53K
116,166
Direct
SaleFeb 17, 2026
Common StockF1F5
1,069
$103.0024
$110.11K
115,097
Direct
SaleFeb 17, 2026
Common StockF1
200
$103.84
$20.77K
114,897
Direct
Filing footnotes · 9
F1The sale reported in the Form 4 was effected pursuant to a Rule 10b5-1 plan adopted by the Reporting Person on February 28, 2025.
F2The price reported in Column 4 is a weighted average price. The securities were sold in multiple transactions at prices ranging from $99.25 to $99.87 per common stock. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F3The price reported in Column 4 is a weighted average price. The securities were sold in multiple transactions at prices ranging from $100.34 to $100.70 per common stock. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F4The price reported in Column 4 is a weighted average price. The securities were sold in multiple transactions at prices ranging from $101.45 to $101.88 per common stock. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F5The price reported in Column 4 is a weighted average price. The securities were sold in multiple transactions at prices ranging from $102.52 to $103.43 per common stock. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F6The price reported in Column 4 is a weighted average price. The securities were sold in multiple transactions at prices ranging from $99.55 to $100.54 per common stock. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F7The price reported in Column 4 is a weighted average price. The securities were sold in multiple transactions at prices ranging from $100.57 to $101.55 per common stock. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F8The price reported in Column 4 is a weighted average price. The securities were sold in multiple transactions at prices ranging from $101.57 to $102.36 per common stock. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F9The price reported in Column 4 is a weighted average price. The securities were sold in multiple transactions at prices ranging from $103.09 to $103.50 per common stock. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
Filed Feb 12, 2026Period of report Feb 10, 20260001104659-26-014546
Transaction
Security
Shares
Price
ValueValue (shares × price)
Held after
Ownership
SaleFeb 12, 2026
Common StockF1F7
292
$96.2627
$28.11K
119,766
Direct
SaleFeb 12, 2026
Common StockF1F8
400
$97.6713
$39.07K
119,366
Direct
SaleFeb 12, 2026
Common StockF1F9
800
$98.9906
$79.19K
118,566
Direct
SaleFeb 12, 2026
Common StockF1
100
$100.10
$10.01K
118,466
Direct
SaleFeb 11, 2026
Common StockF1F4
2,266
$98.37
$222.91K
120,558
Direct
SaleFeb 11, 2026
Common StockF1F5
400
$99.4368
$39.77K
120,158
Direct
SaleFeb 11, 2026
Common StockF1F6
100
$100.8527
$10.09K
120,058
Direct
SaleFeb 10, 2026
Common StockF1F2
1,913
$102.6554
$196.38K
123,624
Direct
SaleFeb 10, 2026
Common StockF1F3
700
$103.6767
$72.57K
122,924
Direct
SaleFeb 10, 2026
Common StockF1
100
$104.76
$10.48K
122,824
Direct
Filing footnotes · 12
F1The sale reported in the Form 4 was effected pursuant to a Rule 10b5-1 plan adopted by the Reporting Person on February 28, 2025.
F10Each restricted stock unit represents a contingent right to receive one share of Issuer common stock.
F11The restricted stock units vest as to 25% of the total shares on each of February 1, 2027, February 1, 2028, February 1, 2029 and February 1, 2030. The restricted stock units have no expiration date.
F12The stock options were granted on February 11, 2026. The options vest and become exercisable in 16 substantially equal installments upon the Reporting Person's completion of each three full months of successive service to the Issuer following the grant date.
F2The price reported in Column 4 is a weighted average price. The securities were sold in multiple transactions at prices ranging from $$102.09 to $103.02 per common stock. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F3The price reported in Column 4 is a weighted average price. The securities were sold in multiple transactions at prices ranging from $103.23 to $103.98 per common stock. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F4The price reported in Column 4 is a weighted average price. The securities were sold in multiple transactions at prices ranging from $97.80 to $98.79 per common stock. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F5The price reported in Column 4 is a weighted average price. The securities were sold in multiple transactions at prices ranging from $98.89 to $99.88 per common stock. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F6The price reported in Column 4 is a weighted average price. The securities were sold in multiple transactions at prices ranging from $100.49 to $100.98 per common stock. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F7The price reported in Column 4 is a weighted average price. The securities were sold in multiple transactions at prices ranging from $96.04 to $96.58 per common stock. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F8The price reported in Column 4 is a weighted average price. The securities were sold in multiple transactions at prices ranging from $97.18 to $97.85 per common stock. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F9The price reported in Column 4 is a weighted average price. The securities were sold in multiple transactions at prices ranging from $98.54 to $99.40 per common stock. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
Filed Feb 6, 2026Period of report Feb 4, 20260001104659-26-011651
Transaction
Security
Shares
Price
ValueValue (shares × price)
Held after
Ownership
SaleFeb 5, 2026
Common StockF1
3,381
$106.063
$358.60K
125,537
Direct
SaleFeb 4, 2026
Common StockF1F2
1,500
$104.7434
$157.12K
130,665
Direct
SaleFeb 4, 2026
Common StockF1F3
1,000
$106.604
$106.60K
129,665
Direct
SaleFeb 4, 2026
Common StockF1F4
747
$107.6654
$80.43K
128,918
Direct
Filing footnotes · 4
F1The sale reported in the Form 4 was effected pursuant to a Rule 10b5-1 plan adopted by the Reporting Person on February 28, 2025.
F2The price reported in Column 4 is a weighted average price. The securities were sold in multiple transactions at prices ranging from $104.34 to $104.99 per common stock. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F3The price reported in Column 4 is a weighted average price. The securities were sold in multiple transactions at prices ranging from $106.31 to $107.15 per common stock. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F4The price reported in Column 4 is a weighted average price. The securities were sold in multiple transactions at prices ranging from $107.32 to $108.08 per common stock. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
Filed Dec 15, 2025Period of report Dec 11, 20250001104659-25-121181
Transaction
Security
Shares
Price
ValueValue (shares × price)
Held after
Ownership
SaleDec 11, 2025
Common StockF1
3,350
$111.00
$371.85K
20,814
Direct
Filing footnotes · 2
F1The sale reported in the Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 7, 2025.
F2The stock options were granted on February 1, 2023. The options vest and become exercisable in 16 substantially equal installments upon the Reporting Person's completion of each three full months of successive service to the Issuer following the grant date.
Filed Nov 24, 2025Period of report Nov 20, 20250001104659-25-115421
Transaction
Security
Shares
Price
ValueValue (shares × price)
Held after
Ownership
SaleNov 20, 2025
Common StockF1
3,350
$105.00
$351.75K
20,814
Direct
Filing footnotes · 2
F1The sale reported in the Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 7, 2025.
F2The stock options were granted on February 1, 2023. The options vest and become exercisable in 16 substantially equal installments upon the Reporting Person's completion of each three full months of successive service to the Issuer following the grant date.
P and S transaction codes only. Grants, gifts, option exercises, tax withholding, and Form 144 notices are not counted as purchases or sales. A row whose filed price fails a plausibility check, or that is not common stock, is listed but left out of the values; a trade reported by several filers is counted once.